Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000813936 | SCV000954320 | pathogenic | Ullrich congenital muscular dystrophy 2; Bethlem myopathy 2 | 2024-12-15 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Ser1580Alafs*3) in the COL12A1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in COL12A1 are known to be pathogenic (PMID: 24334604, 28973083). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with COL12A1-related conditions. ClinVar contains an entry for this variant (Variation ID: 657345). For these reasons, this variant has been classified as Pathogenic. |
Gene |
RCV004820121 | SCV005440852 | likely pathogenic | not provided | 2024-06-24 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; Not observed at significant frequency in large population cohorts (gnomAD); Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease |